NDSS #314
Unifine Pentips
Unifine Pentips is a range of insulin pen needles designed to deliver a comfortable injection experience for people with diabetes.
For routine self-injections, Unifine Pentips offer a:
- Universal fit: compatible with widely used pen injection devices in Australia.*
- Variety of sizes: to suit individual needs and preferences.
Unifine Pentips can be purchased from NDSS access points (usually at your local pharmacy).
Designed for Comfort
Unifine Pentips are designed to ensure a comfortable injection experience and are engineered with a focus on precision, featuring:
Diamond Point Technology
Triple-sharpened needle tips with bevelled edges designed to reduce penetration force.
Opti-Flow Technology
Thin wall technology designed for improved medication delivery and to minimise the injection force required.
Anti-Coring Technology
Ensures clean piercing of the insulin cartridge without fragmentation.
Low Glide Technology
An advanced silicone coating designed to reduce glide force.
The Unifine Pentips Range
Unifine Pentips insulin pen needles come in a variety of lengths and gauges.
They are a universal fit to widely-used pen injection devices* and are double sealed for protection during fitting.
4mm x 32G
5mm x 31G
NDSS #235
6mm x 31G
NDSS #312
Good Injection Technique
When using injectable diabetes medications, choosing the right needle length is important for injecting into the subcutaneous fat layer without leakage or discomfort1. Injecting into muscle can lead to rapid insulin absorption and low blood sugar levels1,2. Shorter needles (4, 5, or 6 mm) are generally recommended for both children and adults with diabetes1,2.
Unifine Pentips pen needles are designed for single-use3 and must be removed immediately after each injection. Reusing needles can lead to complications like lipohypertrophy and infections1.
Compatibility chart
The Unfine Pentips range has a universal fit to widely-used pen injection devices.*
References:
* Some products on the compatibility chart may not have a valid ARTG listing in Australia. Please consult your healthcare professional.
1. Australian Diabetes Educators Association (ADEA). Clinical Guiding Principles for Subcutaneous Injection Technique. Canberra: 2019.
2. Frid, A. et al. (2016). New Insulin Delivery Recommendations. Mayo Clinic proceedings, 91(9), 1231–1255. https://doi.org/10.1016/j.mayocp.2016.06.010
3. Unifine Pentips -IFU-cycle. http://diabetes.ascensia.com.au/pentips-ug/
Social
Always read instructions for use. Consult your healthcare professional if this product is right for you.
©2024 Ascensia Diabetes Care Holdings AG. All rights reserved.
Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners.
Suite 6, Level 3 25 Solent Circuit Baulkham Hills NSW 2153
Always read instructions for use. Consult your healthcare professional if this product is right for you.
©2024 Ascensia Diabetes Care Holdings AG. All rights reserved.
Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners.
